In septic patients with acute lung injury, respiratory distress syndrome [25] or DIC [26], syndecan-1 and hyaluronan are elevated, and may serve as biomarkers to follow for evaluating therapies to improve vascular and endothelial dysfunction. This evidence concerns the gene SDC1 and newborn respiratory distress syndrome.